Blueprint Medicines (BPMC) PT Raised to $95 at Barclays
Tweet
Share
E-mailGet Alerts BPMC Hot Sheet
Price: $129.46 --0%
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Barclays analyst Peter Lawson raised the price target on Blueprint Medicines (NASDAQ: BPMC) to $95.00 (from $90.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Snowflake Inc. (SNOW) PT Raised to $450 at Freedom Broker
- VersaPay Corp. (VPY:CN) PT Raised to Cdn$31 at Keefe, Bruyette & Woods
- Zscaler (ZS) PT Raised to $190 at FBN Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
